fbpx
QQQ
+ 1.31
311.52
+ 0.42%
DIA
-5.22
319.22
-1.66%
SPY
-2.36
384.73
-0.62%
TLT
+ 4.58
133.96
+ 3.31%
GLD
-4.03
169.90
-2.43%

Bet On Gender Equality With This New ETF

by
March 8, 2016 1:11 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Bet On Gender Equality With This New ETF

There is plenty of academic research and data suggesting that public companies with women in key leadership roles and on the board outperform their male-dominated rivals. A new exchange-traded fund from State Street Global Advisors (SSgA), the SPDR SSGA Gender Diversity Index ETF (NYSE: SHE), embraces that theme.

The SPDR SSGA Gender Diversity Index ETF, which debuts Tuesday, follows the “SSGA Gender Diversity Index, which comprises listed US large capitalization companies with the highest levels within their sectors of gender diversity on their boards of directors and in their senior leadership,” according to a statement from Boston-based State Street.

Giving SHE A Closer Look

SHE's underlying index allocates over a third of its combined weight to financial services and healthcare stocks, while technology names command a weight of 15.3 percent. The consumer discretionary and industrial sectors each account for 12.9 percent of SHE's weight.

Top 10 holdings in the index include Warren Buffett's Berkshire Hathaway Inc. (NYSE: BRK-B), Dow component Home Depot Inc (NYSE: HD), Oracle Corporation/b> (NYSE: ORCL) and Amgen, Inc. (NASDAQ: AMGN).

“According to a 2015 MSCI study that explored global trends in gender diversity on corporate boards between December 2009 and August 2015, companies with at least three female board members outperformed others in overall return on equity by more than 36 percent. Despite these findings, American women account for an average of just 16 percent of the members of executive team,” said SSgA in the statement.

The new ETF charges 0.2 percent per year, or $20 for every $10,000 invested.

Image Credit: Public Domain


Related Articles

3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a read more

3 ETFs For The New Look Dow Jones Industrial Average

The venerable Dow Jones Industrial Average is being reshaped in significant fashion. After the close of U.S. read more

Has A Biotech Recovery Started Yet?

This Biotech Stock Could Be Next In The $100B Market Cap Club, Citi Says